All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
DUBLIN – Zealand Pharma A/S has up to now generated its pipeline of peptide drugs internally, but it has gone hunting in biotech's bargain bin to find its first externally sourced asset.
